Buspirone Hydrochloride Tablet
Product Images NDC 71610-266

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Buspirone Hydrochloride (NDC 71610-266). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (2a7745f5 4376 4a0a B040 Fdd441205d8d 01)

FDA Label Image

Figure (2a7745f5 4376 4a0a B040 Fdd441205d8d 02)

Figure (2a7745f5 4376 4a0a B040 Fdd441205d8d 02)
This appears to be a table for dosing instructions for tablets of varying strengths (15mg and 30mg). The table lists the amount of dosage in milligrams for partial tablets of these strengths, ranging from one-third to two-thirds of a tablet. The table also includes the full dosage amount for each strength.*
FDA Label Image

Figure (2a7745f5 4376 4a0a B040 Fdd441205d8d 03)

FDA Label Image

Bottle Label 5 mg (71610 0266 53)

FDA Label Image

Aphena Pharma Solutions (TN)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.